regulatory

News

France reported to be probing Sanofi over Dupixent launch

France’s financial prosecutor has reportedly launched an investigation into Sanofi’s “financial communication” surrounding the launch of its biggest-selling drug Dupixent.

News

EFPIA warns EU reforms will hamstring pharma R&D

A trade organisation representing European pharmaceutical companies warned today that the European Commission’s proposed reforms to pharma legislation could result in the

News

X4 cues up FDA verdict in April for WHIM syndrome drug

The FDA has started a priority review of X4 Pharma’s mavorixafor, angling to become the first therapy for the rare disease WHIM syndrome, with a decision due by 30th April

News

EU clears path for Pfizer’s takeover of Seagen

Pfizer’s $43 billion acquisition of antibody-drug conjugate specialist Seagen has been given the go-ahead by the authorities in the EU, clearing a key remaining obstacle t

Market Access

The UK market: A land of new opportunities for medical devic...

The medical device industry landscape is evolving rapidly, driven both by regulatory changes and the quest for innovation.

News

AZ’s Tagrisso plus chemo get fast FDA review for lung cancer

AstraZeneca will hear back from the FDA in the first quarter of next year about its recent filing of Tagrisso in combination with chemotherapy as a first-line treatment fo

France reported to be probing Sanofi over Dupixent launch

EFPIA warns EU reforms will hamstring pharma R&D

X4 cues up FDA verdict in April for WHIM syndrome drug

EU clears path for Pfizer’s takeover of Seagen

The UK market: A land of new opportunities for medical devic...

AZ’s Tagrisso plus chemo get fast FDA review for lung cancer

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

regulatory

Editor's Picks